Suspected Neratinib Macular Toxicity Presenting As Macular Telangiectasia Type II

The purpose of this case report is to present the first case of neratinib maculopathy. We describe the initial presentation, baseline characteristics, imaging findings, and outcomes. The case report is accompanied by a thorough literature review including possible mechanisms of tyrosine kinase inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Enghelberg, Moises, Kaifee, Syeda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941022/
https://www.ncbi.nlm.nih.gov/pubmed/36824546
http://dx.doi.org/10.7759/cureus.33964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941022/
https://www.ncbi.nlm.nih.gov/pubmed/36824546
http://dx.doi.org/10.7759/cureus.33964

Ejemplares similares